Table 1.
Demographic Data
| Characteristic | Before Outbreak |
During Outbreak |
|||
|---|---|---|---|---|---|
| COVID-19 Negative/Not Tested |
COVID-19 Positive |
||||
| (n = 588) | (n = 329) | P-value | (n = 695) | P-value | |
| Age (years): median [IQR] | 74.7 [63–86.3] | 72.74 [59.1–84] | 0.04 | 73.18 (63–83.3) | 0.08 |
| Gender: n (%) | |||||
| Female | 302 (51.4) | 170 (51.7) | 273 (39.3) | ||
| Male | 286 (48.6) | 159 (48.3) | 0.92 | 422 (60.7) | <0.01 |
| Ethnicity: n (%) | |||||
| Hispanic or Latino | 78 (13.3) | 40 (12.2) | 148 (21.3) | ||
| Non-Hispanic or Non-Latino | 498 (84.7) | 281 (85.4) | 484 (69.6) | ||
| Unknown/Not Reported | 12 (2.0) | 8 (2.4) | 0.83 | 63 (9.1) | <0.01 |
| Race: n (%) | |||||
| Caucasian | 370 (62.9) | 205 (62.3) | 0.85 | 339 (48.8) | <0.01 |
| Black | 83 (14.1) | 34 (10.3) | 0.12 | 91 (13.1) | 0.65 |
| Asian | 44 (7.5) | 33 (10.0) | 0.22 | 51 (7.3) | 1 |
| Other or Unknown | 91 (15.5) | 56 (17) | 0.64 | 214 (31) | <0.01 |
| Comorbidities: n (%) | |||||
| Hyperlipidemia | 305 (51.9) | 151 (45.9) | 0.1 | 357 (51.4) | 0.9 |
| Hypertension | 399 (67.9) | 204 (62) | 0.09 | 487 (70.1) | 0.43 |
| Obesity | 135/579 (23.3) | 111/322 (34.5) | <0.01 | 358/678 (52.8) | <0.01 |
| COPD | 98 (16.7) | 44 (13.4) | 0.21 | 81 (11.7) | 0.01 |
| Heart Failure | 170 (28.9) | 75 (22.8) | 0.05 | 98 (14.1) | <0.01 |
| Coronary Artery Disease | 129 (21.9) | 62 (18.8) | 0.31 | 153 (22.1) | 1 |
| Peripheral Vascular Disease | 45 (7.7) | 28 (8.5) | 0.74 | 59 (8.5) | 0.66 |
| Diabetes | 182 (31.0) | 83 (25.2) | 0.08 | 284 (40.7) | <0.01 |
| Asthma | 53 (9.0) | 36 (10.9) | 0.41 | 65 (9.4) | 0.91 |
| CKD | 117 (19.9) | 71 (21.6) | 0.66 | 138 (19.9) | 1 |
| Cancer | 259 (44.0) | 133 (40.4) | 0.32 | 134 (19.3) | <0.01 |
| Cirrhosis | 25 (4.3) | 19 (5.8) | 0.38 | 10 (1.4) | <0.01 |
| Autoimmune Disorder | 38 (6.5) | 15 (4.6) | 0.3 | 31 (4.5) | 0.14 |
| Previously Seen by Outpatient Palliative Care: n (%) | 85 (14.5) | 47 (14.3) | 1 | 33 (4.7) | <0.01 |
CKD = chronic kidney disease; COPD = chronic obstructive pulmonary disease; COVID-19 = severe acute respiratory syndrome coronavirus 2; IQR = interquartile range.
Bolded values are statistically significant.